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Chinese hamster lung fibroblasts (CHL) arrested in G, by serum starvation reinitiate DNA synthesis in re- 
sponse to either EGF, thrombin or serum. Arrested cells, prelabelled to equilibrium with [3H]inositol and 
receiving 20 mM LiCl prior stimulation, released rapidly large amounts of inositol phosphates when stimu- 
lated with thrombin or serum. In sharp contrast, EGF alone, or in association with insulin, failed to induce 
phosphoinositide breakdown at either early or late stages of EGF stimulation or in growing cells in EGF- 
supplemented serum-free medium. Phospholipase C remained, however, highly activatable by thrombin at 
all stages of EGF stimulation. Since EGF and thrombin are equally potent mitogens for CHL, we conclude 
that hydrolysis of polyphosphoinositides i not an exclusive signalling pathway for commitment o DNA 
replication and cell division. 
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1. INTRODUCTION 
It is now well documented that a variety of 
polypeptide growth factors, when added to quies- 
cent cells, initiate rapidly a common set of 
biochemical events. Among these early and ap- 
parently ‘ubiquitous’ events are stimulation of an 
Na+/H+ antiporter with a subsequent rise in pHi 
[1,2], stimulation of an Na+/K’/Cl- cotrans- 
porter 131, increase in cytoplasmic Ca’+ [4], phos- 
phorylation of ribosomal protein S6 [5,6], and in- 
creased expression of proto-oncogenes c-myc and 
C-$X [7-91. How this common pleiotypic response 
is initiated from the growth factor receptor interac- 
tion and whether the secondary messengers are 
generated by a unique transducing pathway are 
among the most intriguing questions which are still 
unresolved. 
Here, we have analyzed two equally potent 
growth factors, cu-thrombin and epidermal growth 
factor (EGF) for reinitiation of DNA synthesis in 
Chinese hamster lung fibroblasts (CHL). We 
showed that the first action of a-thrombin on 
Go-arrested cells is the hydrolysis of polyphospho- 
inositides [IO], a well-known source of secondary 
messengers [I 1,121. In contrast, EGF alone or 
together with insulin mediates early and late 
mitogenic events without activating inositol lipid 
breakdown. This result strongly suggests that the 
pol~hosphoinositide signalling pathway is not 
essential to set in motion the Go/G1 to S-phase 
transition in fibroblasts and that additional 
transducing pathways must exist. 
2. MATERIALS AND METHODS 
2.1. Materials 
Highly purified cr-thrombin (2660 NIH 
units/mg) was generousfy provided by Dr J.W. 
Fenton II (New York State Department of Health, 
Albany, NY). Mouse EGF was purified in this 
laboratory according to Savage and Cohen [ 13). 
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Crystalline bovine insulin was purchased from 
Sigma. [methyl-3H]Thymidine and myo-[2-3H(n)]- 
inositol were from NEN, France. 
2.2. Cell culture 
Secondary cultures of Chinese hamster lung 
fibroblasts were issued from dissected and tryp- 
sinized newborn animal’s lung and maintained in 
DME medium supplemented with 5% fetal calf 
serum (FCS), penicillin (50 U/ml) and strep- 
tomycin (50 pg/ml) in a humidified atmosphere of 
5% COz/95% air. Experiments were conducted 
with cells taken after 5-10 passages. 
2.3. DNA synthesis 
Reinitiation of DNA synthesis was measured in 
confluent cells arrested in GO by a 24 h incubation 
in serum-free DME medium [14]. Cells were then 
incubated with mitogens for 24 h in DME/Ham’s 
F12 medium (1: 1) containing [3H]thymidine 
(3 PM, 2 &i/ml). They were then rinsed, fixed 
with 5% trichloroacetic acid and the radioactivity 
incorporated assayed after solubilization of the cell 
extracts in 0.1 N NaOH. Determination of the 
percentage of labelled nuclei during the 24 h of 
stimulation with mitogens was performed by 
autoradiography as in [15]. 
2.4. Phosphoinositide hydrolysis 
Confluent cells grown in 35-mm dishes were 
labelled to equilibrium with [3H]inositol (2 &i/ 
ml) for 20 h in serum-free DME medium, the 
period required to bring the cell population to Go. 
Cells were then washed with a Hepes-buffered 
solution containing 20 mM LiCl (110 mM NaCl, 
5 mM KCl, 2 mM CaC12, 1 mM MgCl2 and 
20 mM Hepes/NaOH, pH 7.4) and incubated for 
30 min in this solution before addition of growth 
factor. The hydrolysis of phosphoinositides was 
followed by measuring the rate of inositol 
phosphate released, essentially as in [lo, 161. 
3. RESULTS 
Secondary cultures of CHL fibroblasts arrested 
in GO by serum starvation for 24 h can be 
restimulated to duplicate DNA synthesis and to 
divide by either EGF, mu-thrombin or FCS. Insulin 
alone is a very weak mitogen but potentiates 
strongly the EGF or a-thrombin response (fig. 1A). 
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Fig. 1. Reinitiation of DNA synthesis and phosphoinosi- 
tide breakdown in Go-arrested CHL cells. Confluent 
mean of duplicate dishes. 
cultures of CHL cells were arrested in Go by serum 
starvation as indicated in section 2. (A) Thymidine 
incorporation measured after 24 h stimulation by 
different mitogens: insulin, 10 fig/ml (INS); EGF, 
10 ng/ml; cY-thrombin, 1 U/ml (THR); 10% FCS. 
Incubations were performed in the absence (-) or 
presence (+ ) of insulin. (B) Time course of inositol 
phosphate formation. [3H]Inositol-prelabelled cells were 
incubated for 30 min with 20 mM LiCl prior to stimula- 
tion with insulin (A), EGF (o), EGF + INS (A), THR 
( q ), THR + INS (m), FCS (+) at the same 
concentrations as in A; no addition (0). Total inositol 
phosphates (mono-, bis- and trisphosphate) released 
were measured as reported in section 2. Results are the 
We have recently reported that a rapidly detectable 
biochemical action of cu-thrombin is the hydrolysis 
of polyphosphoinositides [ 10,171. Increase in ino- 
sitol trisphosphate content is detected within 5 s of 
thrombin action. Here we showed that addition of 
20 mM LiCl, an inhibitor of inositol 
monophosphatase [ 181, had no effect on the rate 
of inositol phosphate formation. This rate was not 
measurable over a 60 min period in quiescent cells 
despite the high sensitivity of the assay (fig.lB). 
Treatment of the cells with 1 U/ml of a-thrombin 
or 10% FCS resulted in a rapid and progressive ac- 
cumulation of inositol phosphates. In contrast, ad- 
dition of either insulin or EGF or both together 
had no detectable effect on phosphoinositide 
hydrolysis suggesting that, under this mitogenic 
stimulation, phospholipase C is as ‘quiescent’ as in 
unstimulated cells. We have seen that insulin can 
stimulate by 2-3-fold the mitogenic response of cy- 
thrombin (fig.lA [19]). This potentiating action 
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does not occur at the level of phospholipase C ac- 
tivation, since insulin failed to modify the rate of 
inositol phosphate release when added at maximal 
or submaximal concentration (0.01 U/ml) of 
thrombin (not shown). The percentages of labelled 
nuclei were determined to compare directly the 
respective mitogenic potential of the different 
mitogens used. EGF used at a maximally efficient 
concentration (100 ng/ml) induced DNA replica- 
tion of 43% of the cells, a response higher than 
that observed with 1 U/ml of thrombin (not 
shown) and nearly equivalent o that observed with 
10% FCS (fig.2A). Even under this condition, 
10 100 FCS __v 
EGF 
Fig.2. Percentage of cells reinitiating DNA synthesis and 
phosphoinositide breakdown in response to different 
stimuli. (A) Arrested CHL cells were stimulated for 24 h 
by different growth factors: insulin, EGF at 10 or 
100 ng/ml in the absence ( - ) or presence ( + ) of insulin, 
10% FCS, no addition (C). The percentage of labelled 
nuclei was determined by autoradiography. (B) Inositol 
phosphates released after 1 h stimulation in the absence 
Fig.3. Time course of inositol phosphate release in 
response to EGF or thrombin in EGF-stimulated CHL 
cells. [3H]Inositol-prelabelled CHL cells were either 
arrested in Go by serum starvation (A,B) or grown for 
48 h in serum-free medium containing EGF, insulin and 
transferrin (C). Determination of inositol phosphate 
content was as follows: 20 mM LiCl was added to the 
culture medium 15 min before adding 100 ng/ml EGF 
(A) or 0.01 U/ml cu-thrombin (0). Total inositol 
phosphates was determined at 0, 15 and 60 min after 
stimulation in arrested cells (A), in 8 h EGF-stimulated 
cells (B) and in EGF-growing ceils (C). Points represent 
of growth factor. the mean value of duplicate experiments. 
EGF did not induce the formation of inositol 
phosphates (fig.2B). 
So far we have clearly shown that EGF and in- 
sulin do not stimulate inositol lipid breakdown at 
the early stage of stimulation of Go-arrested cells. 
To rule out completely the involvement of this 
transduction pathway in the mechanism of EGF 
action it was essential to explore it in cells at the 
late stage of the Go/G, transit as well as in the ex- 
ponential growing phase. Fig.3 shows the rate of 
inositol phosphate formation in CHL cells 
stimulated with 100 ng/ml of EGF for different 
time periods: 0 h (A), 8 h EGF-stimulated (B), and 
EGF-growing cells for 48 h (C). As reported 
above, the assay has been conducted in the 
presence of the phosphoinositide cycle blocker 
(LiCl) to amplify the detection of phospholipase C 
activation. Regardless of the conditions used, EGF 
clearly failed to induce the formation of inositol 
phosphates. This absence of response to EGF can- 
not be attributed to a lack of phosphoinositide 
pool since addition of cy-thrombin to EGF- 
stimulated cells resulted in a rapid and massive 
7 
@ @ .75 
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Eff INClJnAlrn TIME ( hour) 
346 
Volume 197, number 1,2 FEBS LETTERS March 1986 
production of inositol phosphates which pro- 
ceeded at almost a constant rate over 1 h of 
stimulation (fig.3A-C). 
4. DISCUSSION 
Our previous studies on the mechanism of action 
of growth factors have been more specifically car- 
ried out with CCL39, an established cell line of 
CHL [20]. Because of the poor mitogenic response 
of Go-arrested CCL39 cells to EGF, we have 
chosen here secondary cultures of CHL 
fibroblasts. Indeed, a direct comparison of the ef- 
fects of EGF and a-thrombin performed in these 
cells was more valid since the two growth factors 
were equally potent not only for reinitiation of 
DNA synthesis but also for supporting growth in 
serum-free medium. In this report, we have shown 
that: (i) unlike mu-thrombin or serum, EGF does not 
stimulate the breakdown of phosphoinositides 
measured with the LiCl-amplified assay; (ii) the 
lack of response to EGF occurs at all stages of the 
cell cycle (early, mid, late Go/G1 transit and ex- 
ponential phase); and (iii) the mitogenic poten- 
tiating effect generally observed with insulin does 
not take place at the level of phospholipase C ac- 
tivation. An important point of this study is that 
EGF-stimulated cells have kept their potential to 
initiate phosphoinositide breakdown in response to 
thrombin (fig.3). However, one might argue that 
two cell types, one responding to EGF and the 
other to thrombin, coexisted in the secondary 
cultures of CHL. This possibility can be ruled out 
since we observed the same results with a clonal 
population of CHL (not shown). 
Whether EGF is capable of stimulating 
phosphatidylinositol turnover in other cell types is 
a matter of controversy. This was reported to be 
the case in A431 cells [21] in which EGF is a 
growth inhibitor. In these cells EGF rapidly 
stimulated the incorporation of 32Pi into 
phosphatidic acid; however, a direct stimulation of 
phosphoinositide hydrolysis has not been 
demonstrated. In contrast, and fully consistent 
with our results, Macphee et al. [22] have shown an 
increase in phosphatidylinositol turnover in resting 
Swiss 3T3 cells stimulated by prostaglandin Fh but 
not by EGF. Such a lack of effect of EGF was 
recently confirmed by Hesketh et al. [23]. 
In conclusion, our results firmly establish that 
EGF alone or in combination with insulin is 
capable of stimulating Go-arrested CHL cells to 
replicate DNA synthesis and to divide without ac- 
tivating phosphatidylinositol turnover. This prop- 
erty is not unique to EGF; we recently observed 
that pure fibroblast growth factor (basic and acidic 
forms of FGF) can initiate early events in CHL 
cells (e.g. rise in cytoplasmic pH, and Ca*+, 
phosphorylation of S6) and DNA replication 
without any detectable induction of phosphoinosi- 
tide breakdown (Moenner et al., in preparation). 
Consistent with this finding is the fact that the 
EGF- and FGF-induced cytoplasmic rise in Ca*+ is 
dependent upon the presence of external Ca*+. In 
contrast, the a-thronibin-induced rise in Ca*+ 
results from mobilization of internal Ca*+ stores, 
presumably as a consequence of cu-thrombin in- 
ositol trisphosphate formation ([ 10,111; I. 
Magnaldo, unpublished). 
It is interesting that evidence in favor of separate 
growth factor transducing pathways, which con- 
verge very early to stimulate the pleiotypic 
response and DNA synthesis, is emerging. An in- 
creasing number of growth-promoting agents (e.g. 
PDGF [24], mu-thrombin [lo], bombesin [25], 
bradykinin, vasopressin [26,27]) appear to initiate 
their action through the activation of polyphos- 
phoinositide breakdown. Little is known about the 
mechanism of activation of this system. However, 
the existence of alternative growth-signalling path- 
ways should help in isolation of inositol lipid cycle- 
deficient mutants. This might provide a promising 
approach to analyze at the molecular level the 
coupling mechanism between growth factor recep- 
tor and phospholipase C. 
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